- Home
- CRBU vs ASPC Comparison
CRBU vs ASPC Comparison
Compare CRBU & ASPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- ASPC
- Stock Information
- Founded
- CRBU 2011
- ASPC 2024
- Country
- CRBU United States
- ASPC Hong Kong
- Employees
- CRBU N/A
- ASPC N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- ASPC
- Sector
- CRBU Health Care
- ASPC
- Exchange
- CRBU Nasdaq
- ASPC Nasdaq
- Market Cap
- CRBU 93.0M
- ASPC 80.9M
- IPO Year
- CRBU 2021
- ASPC 2024
- Fundamental
- Price
- CRBU $0.95
- ASPC $10.07
- Analyst Decision
- CRBU Strong Buy
- ASPC
- Analyst Count
- CRBU 5
- ASPC 0
- Target Price
- CRBU $11.80
- ASPC N/A
- AVG Volume (30 Days)
- CRBU 1.0M
- ASPC 15.4K
- Earning Date
- CRBU 03-10-2025
- ASPC 01-01-0001
- Dividend Yield
- CRBU N/A
- ASPC N/A
- EPS Growth
- CRBU N/A
- ASPC N/A
- EPS
- CRBU N/A
- ASPC N/A
- Revenue
- CRBU $9,994,000.00
- ASPC N/A
- Revenue This Year
- CRBU $3.50
- ASPC N/A
- Revenue Next Year
- CRBU $177.84
- ASPC N/A
- P/E Ratio
- CRBU N/A
- ASPC N/A
- Revenue Growth
- CRBU N/A
- ASPC N/A
- 52 Week Low
- CRBU $0.88
- ASPC $9.95
- 52 Week High
- CRBU $5.15
- ASPC $10.51
- Technical
- Relative Strength Index (RSI)
- CRBU 40.45
- ASPC N/A
- Support Level
- CRBU $0.88
- ASPC N/A
- Resistance Level
- CRBU $1.01
- ASPC N/A
- Average True Range (ATR)
- CRBU 0.08
- ASPC 0.00
- MACD
- CRBU 0.01
- ASPC 0.00
- Stochastic Oscillator
- CRBU 42.00
- ASPC 0.00
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About ASPC A SPAC III Acquisition Corp. Class A Ordinary Shares
A SPAC III Acquisition Corp is a blank check company.